Maria Chiara Del Piccolo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maria Chiara Del Piccolo has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Stefania Tognin
Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience (IoPPN), King’s College London, London, UK
3 shared publications - Andrea Mechelli
Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
2 shared publications - Anna Georgiades
Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience (IoPPN), King’s College London, London, UK
2 shared publications Carys Evans
2 shared publicationsClaire Henderson
2 shared publicationsDavid Lewis
2 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Center for Open Science in PsyArXiv
A clinician-informed framework for precision psychotherapy in psychosis
Background. Despite evidence supporting cognitive behavioural therapy for psychosis (CBTp), engagement and treatment response remain highly variable, and robust predictors are lacking. Existing research may overlook clinically relevant factors. We aimed to identify candidate predictors of CBTp engagement and outcomes by integrating clinicians’ perspectives with the existing literature. Methods. Twenty clinical psychologists experienced in delivering CBTp participated in semi-structured interviews. Using a mixed-methods design, we first identified candidate predictors through inductive framework analysis of unprompted accounts. Clinicians subsequently rated the perceived importance of these and 32 literature-derived factors on a 10-point scale. Mean ratings and variability were examined to characterise clinician agreement. Findings were integrated into a candidate predictor framework linked to available measurement instruments. Results. Clinicians spontaneously identified 38 factors, of which 16 were absent from the literature-derived list. Frequently identified factors included readiness and motivation (90%), cognitive flexibility (85%), social support (80%), previous experiences of care and therapy (70%), and socioeconomic and environmental stability (70%). Clinicians emphasised therapy-related, contextual, and clinical management factors, including expectations of therapy, substance misuse, and medication, which remain underrepresented in prediction research. Literature-derived factors receiving relatively high importance ratings and agreement included insight, cognitive flexibility, hopelessness, and social functioning. Demographic characteristics were generally considered less important. Conclusion. Clinicians identified factors extending beyond those conventionally investigated as predictors of CBTp engagement and outcomes. The resulting clinician-informed measurement framework provides a broader, clinically grounded candidate predictor set to guide prospective studies and the development of personalised prediction models in psychosis. Keywords: Precision psychotherapy, psychological intervention, CBT, psychosis, schizophrenia
- 14 October 2026
- Published by Center for Open Science in PsyArXiv
Open AccessA clinician-informed framework for precision psychotherapy in psychosis
Background. Despite evidence supporting cognitive behavioural therapy for psychosis (CBTp), engagement and treatment response remain highly variable, and robust predictors are lacking. Existing research may overlook clinically relevant factors. We aimed to identify candidate predictors of CBTp engagement and outcomes by integrating clinicians’ perspectives with the existing literature. Methods. Twenty clinical psychologists experienced in delivering CBTp participated in semi-structured interviews. Using a mixed-methods design, we first identified candidate predictors through inductive framework analysis of unprompted accounts. Clinicians subsequently rated the perceived importance of these and 32 literature-derived factors on a 10-point scale. Mean ratings and variability were examined to characterise clinician agreement. Findings were integrated into a candidate predictor framework linked to available measurement instruments. Results. Clinicians spontaneously identified 38 factors, of which 16 were absent from the literature-derived list. Frequently identified factors included readiness and motivation (90%), cognitive flexibility (85%), social support (80%), previous experiences of care and therapy (70%), and socioeconomic and environmental stability (70%). Clinicians emphasised therapy-related, contextual, and clinical management factors, including expectations of therapy, substance misuse, and medication, which remain underrepresented in prediction research. Literature-derived factors receiving relatively high importance ratings and agreement included insight, cognitive flexibility, hopelessness, and social functioning. Demographic characteristics were generally considered less important. Conclusion. Clinicians identified factors extending beyond those conventionally investigated as predictors of CBTp engagement and outcomes. The resulting clinician-informed measurement framework provides a broader, clinically grounded candidate predictor set to guide prospective studies and the development of personalised prediction models in psychosis. Keywords: Precision psychotherapy, psychological intervention, CBT, psychosis, schizophrenia
- Open Access
- 17 September 2026
- Published by Springer Nature in Translational Psychiatry
Predicting relapse risk in first episode psychosis using machine learning and sleep data
Sleep disturbance is common in First Episode Psychosis (FEP) and is associated with psychosis symptom exacerbation and functional decline, yet it remains unclear which sleep features predict relapse. In this longitudinal study, 269 FEP participants reported daily sleep during the first 30 days of the 12-month follow-up period via a smartphone app, including difficulty falling asleep, wake-up frequency, insufficient sleep, and sleep duration. These sleep characteristics were used to predict relapse and positive symptoms over the 12-month follow-up period, with outcomes assessed using structured interviews and clinical records. A Random Forest classifier was developed and validated using stratified nested cross-validation, achieving an AUC of 0.75 ± 0.13 and accuracy of 0.72 ± 0.16. Insufficient sleep and irregular sleep duration were identified as the strongest predictors of relapse risk. These findings were used to develop an open-access interactive web-based platform (a research prototype not intended for clinical use) to predict risk of relapse based on sleep disturbance, demonstrating the potential for real-time monitoring and personalised relapse prevention.
- 17 September 2026
- Published by Springer Nature in Translational Psychiatry
Open AccessPredicting relapse risk in first episode psychosis using machine learning and sleep data
Sleep disturbance is common in First Episode Psychosis (FEP) and is associated with psychosis symptom exacerbation and functional decline, yet it remains unclear which sleep features predict relapse. In this longitudinal study, 269 FEP participants reported daily sleep during the first 30 days of the 12-month follow-up period via a smartphone app, including difficulty falling asleep, wake-up frequency, insufficient sleep, and sleep duration. These sleep characteristics were used to predict relapse and positive symptoms over the 12-month follow-up period, with outcomes assessed using structured interviews and clinical records. A Random Forest classifier was developed and validated using stratified nested cross-validation, achieving an AUC of 0.75 ± 0.13 and accuracy of 0.72 ± 0.16. Insufficient sleep and irregular sleep duration were identified as the strongest predictors of relapse risk. These findings were used to develop an open-access interactive web-based platform (a research prototype not intended for clinical use) to predict risk of relapse based on sleep disturbance, demonstrating the potential for real-time monitoring and personalised relapse prevention.
- Open Access
- 26 August 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e71989
Smartphone-Based Self-Monitoring in First Episode Psychosis: Mixed-Methods Study of Barriers and Facilitators to Engagement
Background: Despite growing interest in smartphone technologies to monitor patient outcomes, only a limited number of studies have investigated the long-term use of smartphone applications in patients with psychosis. Therefore, we have a limited understanding of facilitators and barriers to sustained engagement with these technologies in this population. Objective: This study aimed to examine the impacts of demographic and clinical characteristics on engagement with smartphone-based assessments in people who experienced a first episode of psychosis (FEP); to assess acceptability, barriers, and motivators influencing long-term engagement; to understand how to improve users’ experience in future smartphone-based research; and to better understand participants’ attitude toward the use of digital technologies in clinical settings. Methods: This study used a mixed-methods design. Linear regression models were used to assess the association between demographics and clinical variables (global assessment of functioning [GAF], global functioning [GF], Positive and Negative Syndrome Scale [PANSS], and Hamilton Rating Scale for depression [HAM-D]) and the proportion of completed app-based assessments during the 12-month period. Qualitative data were analyzed using a hybrid deductive and inductive thematic approach. Results: A total of 274 participants were recruited. The average smartphone-assessment completion rate was 14.5% (53/365 daily assessments completed over a 1-year period). No statistically significant associations were found with demographic characteristics, while there was a positive association with the baseline level of functioning (GAF disability: coefficient 0.173; 95% CI 0.022-0.324), GAF symptoms (coefficient 0.155, 95% CI 0.011-0.298), and GF social (coefficient 2.27, 95% CI 0.474-4.061). In contrast, the completion rate was negatively associated with PANSS general subscales (coefficient, −0.589, 95% CI −0.923 to −0.254) and depression (coefficient, −0.524, 95% CI −0.874 to −0.174). A total of 20 participants completed the qualitative sub-study. Participants acknowledged the ease of using the app and the user-friendly interface. They also valued the repetitive nature of the assessments, noting that it encouraged self-reflection. However, daily assessments felt time-consuming and repetitive over time, and some participants found it challenging to remain engaged due to competing life priorities. While some participants felt the app lacked tangible benefits, others reported indirect benefits from tracking their daily experiences. The opportunity to contribute to research was highly valued, as well as the importance of human connection with the researchers in sustaining long-term engagement. Participants made several suggestions: reducing the frequency of smartphone assessments to 1‐2 times per week, integrating passive and active monitoring tools, and incorporating individualized features. Most participants supported the idea of using an app as part of their clinical care, provided data security and privacy were adequately addressed. Conclusions: Our study suggests that smartphone-based technologies are an acceptable monitoring tool for patients with first episode of psychosis. While participants expressed interest in using smartphone apps as a clinical tool, they emphasized that this should complement, rather than replace, the therapeutic relationship. Patients experiencing more severe symptoms may require additional support and incentives to sustain engagement over time.
- 26 August 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e71989
Open AccessSmartphone-Based Self-Monitoring in First Episode Psychosis: Mixed-Methods Study of Barriers and Facilitators to Engagement
Background: Despite growing interest in smartphone technologies to monitor patient outcomes, only a limited number of studies have investigated the long-term use of smartphone applications in patients with psychosis. Therefore, we have a limited understanding of facilitators and barriers to sustained engagement with these technologies in this population. Objective: This study aimed to examine the impacts of demographic and clinical characteristics on engagement with smartphone-based assessments in people who experienced a first episode of psychosis (FEP); to assess acceptability, barriers, and motivators influencing long-term engagement; to understand how to improve users’ experience in future smartphone-based research; and to better understand participants’ attitude toward the use of digital technologies in clinical settings. Methods: This study used a mixed-methods design. Linear regression models were used to assess the association between demographics and clinical variables (global assessment of functioning [GAF], global functioning [GF], Positive and Negative Syndrome Scale [PANSS], and Hamilton Rating Scale for depression [HAM-D]) and the proportion of completed app-based assessments during the 12-month period. Qualitative data were analyzed using a hybrid deductive and inductive thematic approach. Results: A total of 274 participants were recruited. The average smartphone-assessment completion rate was 14.5% (53/365 daily assessments completed over a 1-year period). No statistically significant associations were found with demographic characteristics, while there was a positive association with the baseline level of functioning (GAF disability: coefficient 0.173; 95% CI 0.022-0.324), GAF symptoms (coefficient 0.155, 95% CI 0.011-0.298), and GF social (coefficient 2.27, 95% CI 0.474-4.061). In contrast, the completion rate was negatively associated with PANSS general subscales (coefficient, −0.589, 95% CI −0.923 to −0.254) and depression (coefficient, −0.524, 95% CI −0.874 to −0.174). A total of 20 participants completed the qualitative sub-study. Participants acknowledged the ease of using the app and the user-friendly interface. They also valued the repetitive nature of the assessments, noting that it encouraged self-reflection. However, daily assessments felt time-consuming and repetitive over time, and some participants found it challenging to remain engaged due to competing life priorities. While some participants felt the app lacked tangible benefits, others reported indirect benefits from tracking their daily experiences. The opportunity to contribute to research was highly valued, as well as the importance of human connection with the researchers in sustaining long-term engagement. Participants made several suggestions: reducing the frequency of smartphone assessments to 1‐2 times per week, integrating passive and active monitoring tools, and incorporating individualized features. Most participants supported the idea of using an app as part of their clinical care, provided data security and privacy were adequately addressed. Conclusions: Our study suggests that smartphone-based technologies are an acceptable monitoring tool for patients with first episode of psychosis. While participants expressed interest in using smartphone apps as a clinical tool, they emphasized that this should complement, rather than replace, the therapeutic relationship. Patients experiencing more severe symptoms may require additional support and incentives to sustain engagement over time.